Contraceptive use by obese women 1 year postpartum

Contraception

Volumn 80, Issue 5, 2009, Pages 463-468

  Chin, Jeanette R ^a,b   Swamy, Geeta K ^b   Østbye, Truls ^b,c   Bastian, Lori A ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Singapore Graduate Medical School   (Singapore)

Author keywords

AMP; Contraception; Obese; Postpartum; Pregnancy; Unintended

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY MASS; BREAST FEEDING; CHRONIC DISEASE; CONTRACEPTION; CONTROLLED STUDY; EDUCATION; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INSTRUMENT STERILIZATION; INTRAUTERINE CONTRACEPTIVE DEVICE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; PARITY; PUERPERIUM; RACE; SECONDARY ANALYSIS; VAGINA CONTRACEPTION; WEIGHT REDUCTION;

ADOLESCENT; ADULT; CONTRACEPTION; CONTRACEPTION BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MATERNAL BEHAVIOR; NORTH CAROLINA; OBESITY; OVERWEIGHT; POSTPARTUM PERIOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349775729     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.03.017     Document Type: Article

References (40)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
2. Cedergren M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 103 (2004) 219-224
3. Weiss J.L., Malone F.D., Emig D., et al. Obesity, obstetric complications and cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol 190 (2004) 1091-1097
4. Sebire N.J., Jolly M., Harris J.P., et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 25 (2001) 1175-1182
5. Young T.K., and Woodmansee B. Factors that are associated with cesarean delivery in a large private practice: the importance of prepregnancy body mass index and weight gain. Am J Obstet Gynecol 187 (2002) 312-318
6. Perlow J.H., and Morgan M.A. Massive maternal obesity and perioperative cesarean morbidity. Am J Obstet Gynecol 170 (1994) 560-565
7. Myles T.D., Gooch J., and Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol 100 5 Pt 1 (2002) 959-964
8. Kabiru W., and Raynor B.D. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol 191 (2004) 928-932
9. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24--9, 46.
10. Beck L.F., Morrow B., Lipscomb L.E., et al. Prevalence of selected maternal behaviors and experiences, Pregnancy Risk Assessment Monitoring System (PRAMS), 1999. MMWR Surveill Summ 51 (2002) 1-27
11. Kost K., and Forrest J.D. Intention status of U.S. births in 1988: differences by mothers' socioeconomic and demographic characteristics. Fam Plann Perspect 27 (1995) 11-17
12. Kaneshiro B., Edelman A., Carlson N., Nichols M., and Jensen J. The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth. Contraception 77 (2008) 234-238
13. Chuang C.H., Chase G.A., Bensyl D.M., and Weisman C.S. Contraceptive use by diabetic and obese women. Womens Health Issues 15 (2005) 167-173
14. Huber L.R., Hogue C.J., Stein A.D., et al. Contraceptive use and discontinuation: findings from the contraceptive history, initiation, and choice study. Am J Obstet Gynecol 194 (2006) 1290-1295
15. Gu S., Sivin I., Du M., et al. Effectiveness of Norplant implants through seven years: a large-scale study in China. Contraception 52 (1995) 99-103
16. Grubb G.S., Moore D., and Anderson N.G. Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience. Contraception 52 (1995) 287-296
17. Zieman M., Guillebaud J., Weisberg E., Shangold G.A., Fisher A.C., and Creasy G.W. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 77 2 Suppl 2 (2002) S13-S18
18. Holt V.L., Scholes D., Wicklund K.G., Cushing-Haugen K.L., and Daling J.R. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 105 (2005) 46-52
19. Holt V.L., Cushing-Haugen K.L., and Daling J.R. Body weight and risk of oral contraceptive failure. Obstet Gynecol 99 5 Pt 1 (2002) 820-827
20. Vessey M. Oral contraceptive failures and body weight: findings in a large cohort study. J Fam Plann Reprod Health Care 27 (2001) 90-91
21. Brunner Huber L.R., Hogue C.J., Stein A.D., Drews C., and Zieman M. Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina. Ann Epidemiol 16 (2006) 637-643
22. Brunner Huber L.R., and Hogue C.J. The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception. Matern Child Health J 9 (2005) 413-420
23. Brunner Huber L.R., and Toth J.L. Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth. Am J Epidemiol 166 (2007) 1306-1311
24. Santelli J., Rochat R., Hatfield-Timajchy K., et al. The measurement and meaning of unintended pregnancy. Perspect Sex Reprod Health 35 (2003) 94-101
25. Trussell J, Vaughan B, Stanford J. Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:246--7, 60.
26. Ostbye T., Krause K.M., Brouwer R.J., et al. Active Mothers Postpartum (AMP): rationale, design, and baseline characteristics. J Womens Health 17 (2008) 1567-1575
27. Kost K., Singh S., Vaughan B., Trussell J., and Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 77 (2008) 10-21
28. National Heart, Lung and Blood Institute (NHLBI). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/txgd/411.htm [Accessed November 19, 2008]
29. Harrell F. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis (2001), Springer, New York
30. Kennedy K.I., and Visness C.M. Contraceptive efficacy of lactational amenorrhoea. Lancet 339 (1992) 227-230
31. Ramlau-Hansen C.H., Thulstrup A.M., Nohr E.A., Bonde J.P., Sorensen T.I., and Olsen J. Subfecundity in overweight and obese couples. Hum Reprod 22 (2007) 1634-1637
32. Holing E.V., Beyer C.S., Brown Z.A., and Connell F.A. Why don't women with diabetes plan their pregnancies?. Diabetes care 21 (1998) 889-895
33. St James P.J., Younger M.D., Hamilton B.D., and Waisbren S.E. Unplanned pregnancies in young women with diabetes. An analysis of psychosocial factors. Diabetes care 16 (1993) 1572-1578
34. Kaneshiro B., Jensen J.T., Carlson N.E., Harvey S.M., Nichols M.D., and Edelman A.B. Body mass index and sexual behavior. Obstet Gynecol 112 (2008) 586-592
35. World Health Organization. Medical eligibility criteria for contraceptive use, third edition. http://www.who.int/reproductive-health/publications/mec/index.htm [accessed December 31, 2008]
36. Blaszyk H., Wollan P.C., Witkiewicz A.K., and Bjornsson J. Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors. Virchows Arch 434 (1999) 529-532
37. Anderson Jr. F.A., Wheeler H.B., Goldberg R.J., Hosmer D.W., and Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 152 (1992) 1660-1664
38. Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160 (2000) 3415-3420
39. La Vecchia C., Altieri A., Franceschi S., and Tavani A. Oral contraceptives and cancer: an update. Drug Saf 24 (2001) 741-754
40. Hubacher D., and Grimes D.A. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 57 (2002) 120-128